Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Low CD4 count important risk factor for oral HPV infection in patients with HIV

A low CD4 count is the single most important risk factor for oral human papillomavirus (HPV) infection in HIV-positive patients, investigators from the United States report in the

Published
23 February 2015
By
Michael Carter
HPV Vaccination Not Associated with Increase in Sexually Transmitted Infections

A barrier to human papillomavirus (HPV) vaccination has been the concern that it may promote unsafe sexual activity, but a new study of adolescent girls finds that HPV vaccination was not associated with increases in sexually transmitted infections (STIs), according to an article published online by JAMA Internal Medicine.

Published
11 February 2015
From
JAMA press release
Low CD4 count, suboptimal HIV treatment linked to higher anal cancer risk

People with HIV who experienced extensive immune deficiency or who used early antiretroviral drugs before the advent of combination highly-active antiretroviral therapy (HAART) in the mid-90s may be at greater risk for developing anal cancer, according to a retrospective analysis published in the January 28 edition of AIDS.

Published
23 January 2015
From
HIVandHepatitis.com
Anal Cancer and HPV: What do Gay Men Need to Know?

A CDC recommendation report issued by the Advisory Committee on Immunization Practices released late this summer calls for a better understanding of anal cancer development and screening among a population at high risk—men who have sex with men (MSM). Although there’s still uncertainty about the best way to screen for and treat anal cancer, here’s what we know right now about who gets it, and what to look out for if you’re worried.

Published
14 January 2015
From
BETA blog
Bone metastases in prostate cancer blocked by HIV drug

Experiments in mice and in humans have indicated that the HIV drug maraviroc (Celsentri/Selzentry) could be used to prevent the spread of metastases (secondary caners) from prostate and other cancers. Experiments in mice showed a 60% reduction in metastases in animals treated with maraviroc.

Published
04 January 2015
From
Medical news today
Smoking doubles risk of death for patients taking HIV therapy

Smoking doubles the mortality risk for people with HIV taking antiretroviral therapy, a study published in AIDS shows. Smokers had an increased risk of death from cardiovascular disease

Published
16 December 2014
By
Michael Carter
Heterosexual transmission of HPV to male oral tract via oral/genital route indicated by partner data

A recent study claims to be the first to have established the association of oral infection in males with sexual behaviour, not just on the basis of their reported sexual behaviour, but through the collection of data from their partners.

Published
15 December 2014
From
BMJ Blogs
HIV-infected adults diagnosed with age-related diseases at similar ages as uninfected adults

HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.

Published
10 December 2014
From
Science Daily
HPV vaccine, riskier sexual activity not linked researchers say

Sexual behavior of teenage girls does not appear to be impacted by the human papilloma virus (HPV) vaccine, according to Queen's University, Canada researchers Drs. Leah Smith and Linda Lévesque.

Published
09 December 2014
From
Eurekalert
HIV-positive patients with lymphoma should no longer be excluded from receiving blood stem cell transplants as treatment

HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised immune systems would have a higher risk of infection and poor graft function due to their need for HIV medications. Results from the clinical trial, presented at the American Society of Hematology (ASH) meetings, show the concern of additional risk is unfounded.

Published
08 December 2014
From
Business Wire (press release)
← First12345...36Next →

Filter by country